Inflammatory agents such as lipopolysaccharide (LPS) down-regulate the hepatic expression of many cytochrome P450 (CYP) mRNAs and proteins. Previous studies suggested that suppression of some CYP mRNAs could involve the regulation or modulation of the nuclear receptors peroxisome proliferator activated receptor alpha (PPARα) or pregnane X receptor (PXR). To determine the involvement of these receptors in CYP down-regulation, PPARα knockout (KO), PXR KO, and appropriate wildtype (WT) mice were administered either saline or 1 mg/kg LPS. Hepatic mRNA and protein expression of several CYP isoforms, interleukin (IL)-1β, IL-6, tumor necrosis factor alpha (TNFα), α1-acid glycoprotein (AGP), and fibrinogen (FBG) were examined 16 hours later. LPS administration significantly decreased the hepatic expression of CYP1A2, 2A5, 2C29, 2E1, 3A11, 4A10, and 4A14 mRNAs in both groups of PPARα and PXR mice, whereas CYP3A13 mRNA was increased slightly in PPARα WT and KO mice, but not in PXR mice. Effects of LPS administration on mouse hepatic CYP proteins (probed using rat P450 2C, 3A, 4A, and 2E antibodies) were consistent with mRNA results in most cases. LPS treatment significantly increased IL-1β, IL-6, TNFα, AGP, and FBG mRNA in both PPARα and PXR mice, with the greatest effect observed with TNFα. Because decreases in CYP mRNA expression were essentially identical in both WT and KO mice for both nuclear receptors, these data indicate that down-regulation of CYP during inflammation does not require the nuclear receptors PPARα and PXR.
JPET 085456

INTRODUCTION
Cytochromes P450 (CYP) are drug-metabolizing enzymes that oxidize numerous endogenous and foreign compounds, including the majority of therapeutic agents, resulting in drug activation or inactivation. CYP gene expression is regulated by several factors, including gender, microsomal enzyme inducers, age, diet, and hormones.
During inflammation and infection both CYP expression and metabolic activities in liver and extrahepatic tissues can be downregulated (reviewed by Morgan, 2001; Renton, 2004) ; however, some CYP activities are induced or unchanged. As such, alterations in CYP expression and activities during inflammation can lead to increased or decreased drug efficacy or changes in the metabolism of physiological substrates. , 2001 Renton, 2004) . Due to the complexity of the inflammatory response, the in vivo contributions of individual cytokines are difficult to determine. Studies using cytokine-or cytokine receptor-null mice to investigate LPS-mediated CYP down-regulation have reported differential dependence of CYP down-regulation on cytokines, contingent on the CYP subfamily or model of inflammation being studied (Warren et al., 1999; Seiwert et al., 2000; Ashino et al., 2004) . As such, LPS-mediated CYP down-regulation is regulated through multiple pathways.
There is some evidence that hepatic CYP down-regulation during inflammation may be mediated by modulation of nuclear receptors. Drug-induced transcription of CYP is mediated by nuclear receptors, including the peroxisome proliferator activated receptor alpha (PPARα, NR1C1) and the pregnane X receptor (PXR, NR1I2). Reductions in mRNA levels of PPARα, PXR, retinoid X receptor (RXR), and liver X receptor (LXR) have been recently reported in liver and intestine of rodents treated with LPS (Beigneux et al, 2000; Kalitsky-Szirtes et al., 2004) , and these findings have been associated with CYP down-regulation. An earlier study from our laboratory found that LPS down-regulation of hepatic CYP2A5, 2C29, and 3A11 mRNAs was attenuated in PPARα knockout (KO) mice (Barclay et al., 1999) . Moreover, Beigneux et al. (2002) associated a reduction in CYP3A and 2B10 mRNA with decreases in the expression of PXR, the constitutive androstane receptor (CAR), and RXRα after LPS treatment, with similar results found for PXR and CYP3A11 (Xu et al., 2004 LPS produces a maximal suppression of total CYP and rat CYP2C11 (Morgan, 1989) , and induces CYP4A expression in rat liver (Sewer et al., 1996 (Sewer et al., , 1997 Mitchell et al., 2001) . At 16 hours after injection, livers were collected and stored at -80°C until RNA or microsome preparation. This time point was chosen based on previous experiments reporting LPS-mediated down-regulation of nuclear receptors at 16 hours (Beigneux et al., 2002 were used in each group (n = 5, PPARα; n = 6, PXR).
Preparation of Total RNA. Total RNA was prepared using RNA-Bee isolation reagent according to the manufacturer's instructions (Tel-test, Friendswood TX).
Total RNA concentration was determined spectrophotometrically by measuring absorbance at 260 nm, and RNA purity and integrity was confirmed by formaldehyde-agarose gel electrophoresis followed by visualization with ethidium bromide.
Microsome Preparation. Liver microsomes were prepared by differential centrifugation and stored at -80°C (Haugen and Coon, 1976) . Microsomal protein concentrations were determined by the method of Lowry et al. (1951) using bovine serum albumin as the standard. and obtained desalted and lyophilized. Primers were diluted to 100 µM in deionized water, and stored at -80°C. Designed primer sequences are listed in Table 1 ; other primer sequences used (CYP1A2, 2E1, 3A11, IL-1β) were published previously (Pan et al., 2000; Overbergh et al., 2003) . In addition to the GAPDH primers listed in Table 1 , other GAPDH primers were designed for use at annealing temperatures corresponding to the various primer sets.
Quantitative Reverse Transcriptase PCR (real-time PCR). Real-time RTPCR
was performed using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Bedford, MA), to determine CYP mRNA expression in mouse liver.
Reactions were performed in a total volume of 25 µl using SyBr Green Master
Mix reagent (Applied Biosystems); 2 µl of cDNA/sample was used as template for the reaction, with 10 µM forward and reverse primers. Both CYP and GAPDH amplification was done in duplicate wells using the same sample. Thermal cycling conditions included 2 min at 50°C and 10 min at 95°C, followed by 40 cycles of 95°C for 15 s and 1 min at the appropriate annealing temperature for each CYP (listed in Table 1 ). This technique allows, by means of fluorescence emission, identification of the cycling point when PCR product is detectable (threshold cycle or C t value). To normalize the amount of total mRNA present in each reaction, levels of the housekeeping gene GAPDH were monitored in parallel samples. Results are expressed as relative levels of CYP mRNA, referred to as control samples (the calibrator), chosen to represent 1x expression of the gene. The amount of target (CYP in treated sample), normalized to an endogenous reference (GAPDH) and relative to the calibrator (control CYP sample), was defined by the C t method as described by Livak and Schmittgen (2001) . All primer sets yielded a single PCR product of expected size by agarose gel electrophoresis, and specificity was routinely monitored by checking product melting curves (dissociation curves) in each reaction well. PPARα KO mice for all these mRNAs (Fig. 1) . Of the CYP isoforms studied, CYP2A5 mRNA was the most affected by LPS exposure (7% of control) and 2C29 mRNA was least affected (46% of control). PPARα KO mice had slightly higher basal levels of CYP2C29 mRNA compared to WT mice. In contrast to the other isoforms, CYP3A13 mRNA expression in PPARα WT mice increased significantly after LPS exposure (153%), and was increased in PPARα KO mice (139%) as well, although the latter comparison did not reach significance.
Expression of CYP4A10 and 4A14 mRNAs was reduced by LPS treatment to 19% and 29% of control in PPARα WT mice, respectively. CYP4A mRNA expression in PPARα KO mice was barely measurable by sensitive real-time PCR methods (control levels, 0.0003 relative units).
In general, effects of LPS on CYP proteins (2C, 3A, 4A, and 2E) corresponded with real-time PCR results for the CYP mRNAs (Fig. 2) . LPS administration decreased hepatic CYP2C, 3A, and 2E proteins in both PPARα WT and KO mice, although the decrease was not significant in WT mice for CYP2C (Fig. 2) .
LPS tended to decrease CYP4A protein expression in PPARα WT mice, As expected, LPS administration increased mRNA expression of proinflammatory cytokines and acute phase proteins (Fig. 3) . LPS significantly induced mRNAs for IL-1β, IL-6, TNFα, AGP, and FBG in livers of PPARα WT mice by 380%, 1013%, 2615%, 652%, and 745%, respectively. LPS also induced the same mRNAs in PPARα KO mice, although the level of induction was slightly attenuated in each case. LPS exposure significantly decreased hepatic expression of CYP1A2, 2A5, 2C29, 2E1, 3A11, 4A10, and 4A14 mRNAs in PXR WT and KO mice (Fig. 4) .
Effect of LPS
CYP2A5 mRNA was most affected by LPS exposure (13% of control) and 2E1 mRNA levels were least affected (43% of control), with higher basal CYP2A5 and 2E1 mRNA in PXR KO mice as compared to WT controls. Additionally, basal 3A11 mRNA levels were 2-fold higher in PXR KO mice (Fig. 4) . In contrast, there was little effect of LPS treatment on basal CYP3A13 mRNA expression in PXR WT and KO mice.
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 5) , in contrast to the effects on CYP2E1 mRNA levels (Fig.   4 ). CYP4A proteins in PXR WT mice were the most significantly affected after LPS administration, although variability in individual protein samples prevented this significance in PXR KO mice.
Effect of LPS Treatment on Hepatic Cytokine and Acute Phase Protein mRNA Expression in PXR Wildtype and Knockout Mice.
LPS treatment tended to induce IL-1β and IL-6 mRNA expression in PXR WT and KO mice, although the increases were not significant (Fig. 6 ). LPS exposure induced TNFα mRNA in PXR WT (406%), and had a greater response in PXR KO mice (638% of control). As expected, hepatic mRNA expression of AGP was significantly increased after LPS treatment in both WT (549%) and KO (1068%) mice. Similar results were observed with FBG in PXR WT (280%) and KO (582%) mice. Overall, the responses tended to be slightly greater in the PXR KO mice.
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DISCUSSION
Infection or inflammatory stimuli such as lipopolysaccharide (LPS) can alter hepatic cytochrome P450s (CYP) at the mRNA and protein levels, resulting in changes in both expression and activities (Morgan, 2001 ). Drug-induced CYP transcription is controlled by nuclear receptors, which may be involved in CYP down-regulation during inflammation. In this study, we sought to determine the involvement of the nuclear receptors PPARα and PXR in the down-regulation of several CYP isoforms after LPS-induced inflammation using mice deficient in these nuclear receptors. Our data show down-regulation of mRNA expression of CYPs 1A2, 2A5, 2C29, 2E1, and 3A11 during inflammation in WT mice, with essentially identical results in both PPARα and PXR KO mice, indicating that down-regulation of these CYPs during inflammation is not a consequence of down-regulation of the nuclear receptors PPARα and PXR.
The nuclear receptor PPARα has been implicated in inflammatory pathways, and induction of PPARα target genes may be important in termination of the action of inflammatory mediators (Morgan, 2001; Barbier et al., 2004) . PPARα primarily regulates lipid metabolism, glucose homeostasis and stimulates the β-oxidative degradation of fatty acids (Chinetti et al., 2000) . Target genes of PPARα include CYP4A subfamily enzymes, β-oxidation enzymes, and fatty acid binding proteins (Aoyama et al., 1998) . During LPS-induced inflammation, both hepatic and renal CYP4A mRNAs are induced in rats (Sewer et al., 1996 (Sewer et al., , 1997 Mitchell et al., 2001 ), whereas in this study we observed down-regulation of hepatic CYP4A10
This article has not been copyedited and formatted. The final version may differ from this version. and 4A14 mRNAs in PPARα WT mice after LPS exposure (Fig. 1 ) in agreement with our previous report (Barclay et al., 1999) . It could be speculated that downregulation of CYP4A mRNA after LPS exposure could be directly linked to downregulation of PPARα mRNA levels. Although hepatic PPARα mRNA levels were not measured in our mice, Tai et al. (2003) observed down-regulation of PPARα mRNA in female mice (50% of control) 2 hours after LPS exposure, with recovery to baseline levels at 24 hours. Therefore, it seems unlikely that the extensive down-regulation of CYP4A10 and 4A14 mRNAs after a 16-hour LPS exposure (to 19% and 29% of control) is due solely to down-regulation of PPARα mRNA.
Our previous investigation found that LPS treatment down-regulated hepatic CYP2A5, 2C29, and 3A11 mRNA in PPARα WT mice, and that the effects on these CYP isoforms were attenuated or blocked in PPARα KO mice (Barclay et al., 1999) . In contrast, our current data indicate similar down-regulation of CYP2A5, 2C29, and 3A11 mRNAs after LPS exposure in both PPARα WT and KO mice (Fig. 1) as well as down-regulation of CYP proteins (Fig. 2) , suggesting that PPARα is not involved in down-regulation of these CYPs during inflammation. In our previous study, mRNA levels were determined by Northern blotting, used fewer animals, and had a slightly longer LPS exposure time (24 vs 16 hours). The current findings using the more sensitive and quantitative realtime PCR method, and a larger number of animals, conclusively establish that
PPARα is not involved in down-regulation of the CYPs studied here (1A2, 2A5,
2C29, 2E1, 3A11).
This article has not been copyedited and formatted. The final version may differ from this version. Little is known about PXR and inflammatory pathways. Activation of PXR regulates xenobiotic-inducible CYP3A gene expression in mice (Kliewer et al., 1998) , as well as CYP2B and 2C, glutathione S-transferases, sulfotransferases, UDP-glucuronosyltransferases, organic anion transporter peptide 2, and multidrug resistance protein 3 . Studies have associated down-regulation of PXR after LPS administration with reductions in PXRregulated CYP (Beigneux et al., 2002; Xu et al., 2004; Teng and Piquette-Miller, 2005) . As shown in Fig. 4 , we observed similar down-regulation of CYP1A2, 2A5, 2C29, 2E1, 3A11, 4A10, and 4A14 mRNAs in both PXR WT and KO mice, indicating that PXR is not required for CYP down-regulation during inflammation.
These observations corroborate a recent finding by Teng and Piquette-Miller (2005) , who also demonstrated down-regulation of CYP3A11 mRNA in both WT and PXR KO mice after a shorter exposure to a higher dose of LPS (5 mg/kg, 6 hours). Both our data and the Teng study indicate higher basal levels of CYP3A11 mRNA in PXR KO mice compared to PXR WT mice. Regardless of the higher basal levels in the PXR KO, the percent reduction of CYP3A11 by LPS was similar in both PXR WT and PXR KO mice (81.5% and 79.6% reduction, respectively). In contrast to the other CYP isoforms, CYP3A13 was not affected by LPS treatment in our PXR study (Fig. 6 ), although PXR is reported to be involved in its basal expression (Anakk et al., 2003) . Interestingly, LPS treatment induced CYP3A13 mRNA in the PPARα experiment (Fig. 1) . This difference in Cheng et al., 2003) . Overall, the combination of reduced activities of several TFs could contribute to the CYP suppression (Cheng et al., 2003) .
The down-regulation of multiple CYP isoforms during inflammation can be mimicked by in vivo and in vitro treatment with proinflammatory cytokines such as IL-1β, IL-6, and TNFα (Morgan, 2001) . It is possible that cytokines produced in vivo may mediate CYP down-regulation in our study, although this cannot be determined from these data because plasma cytokine levels were not determined, and the hepatic cytokine mRNAs were not measured at peak times (1-6 hours). Although our studies show that PPARα and PXR are not directly involved in CYP down-regulation, it is possible that these nuclear receptors are involved in the modulation of proinflammatory cytokines. The LPS-mediated induction of TNFα mRNA was attenuated in PPARα KO mice (Fig. 3) , suggesting the involvement of PPARα in regulation of TNFα expression. Hill et al. (1999) have observed that PPARα activators up-regulate TNFα expression in mice Several studies have investigated cytokine involvement in CYP decreases during LPS-induced inflammation, using cytokine-or cytokine receptor-null mice. These studies have generally shown no significant differences between WT and KO mice (Warren et al., 1999; Ashino et al., 2004; Siewert et al., 2000) , suggesting that cytokines signal redundantly to down-regulate CYPs during LPS-induced inflammation. Also, LPS may alter CYP expression by mechanisms that differ depending on the LPS dose. In addition to cytokines, reactive oxygen species have been suggested to contribute to LPS down-regulation of PXR and CYP3A11 mRNA (Xu et al., 2004) . The same authors have also recently shown that the antioxidant melatonin attenuates LPS-induced down-regulation of PXR and CYP3A11 (Xu et al., 2005) .
In summary, we have conclusively shown that the nuclear receptors PPARα and PXR are not required for the down-regulation of CYP isoforms during LPSinduced inflammation, as we observed similar down-regulation of several CYP for each group (n = 5), and designations denote significant differences (p<0.05) from WT control (*) or KO control (#). Values represent means ± S.E.M. for each group (n = 5), and designations denote significant differences (p<0.05) from WT control (*) or KO control (#). for each group (n = 6), and designations denote significant differences (p<0.05) from WT control (*) or KO control (#). Values represent means ± S.E.M. for each group (n = 6), and designations denote significant differences (p<0.05) from WT control (*) or KO control (#).
